Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05786222 · ClinicalTrials.gov registry record · NA
Permanent Supportive Housing Overdose Prevention
A NA study, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 1,350
- Enrollment target
NCT05786222 is a NA study that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 1,350 participants.
The verdict
NCT05786222, a NA study, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,350 participants
- Enrollment target
Study Summary
Permanent supportive housing (PSH), the gold standard intervention for ending chronic homelessness, has expanded rapidly across the U.S. in recent years. Due to a confluence of individual and environmental risk factors, PSH tenants face heightened risk for overdose. While evidence-based practices to prevent overdose exist, they have not been broadly implemented in PSH settings. This study will address this research to practice gap by studying the implementation of evidence-based practices to prevent overdose in 20 PSH buildings in New York. In a community-partnered stepped wedge randomized controlled trial, the investigators will study a package of implementation strategies that includes an implementation toolkit, tenant and staff implementation champions, limited practice facilitation, and learning collaboratives. Outcomes will be examined using surveys and qualitative interviews with PSH tenants and staff; observation; and analysis of Medicaid claims data.
Interventions
- BEHAVIORAL CSH-Delivered Overdose Prevention Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05786222
The ClinicalTrials.gov registry entry for NCT05786222 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CSH-Delivered Overdose Prevention Support is the first listed.
NCT05786222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05786222 about?
NCT05786222 is a clinical study titled "Permanent Supportive Housing Overdose Prevention". Permanent supportive housing (PSH), the gold standard intervention for ending chronic homelessness, has expanded rapidly across the U.S. in recent years. Due to a confluence of individual and environmental risk factors, PSH tenants face heightened risk for overdose. While evidence-based practices to...
What is the current status of trial NCT05786222?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,350 participants. The study started on 2023-09-26. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT05786222?
The interventions under investigation include: CSH-Delivered Overdose Prevention Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05786222?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.